| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |